Hypochlorous acid formulations and methods for treating skin conditions
The present invention in various aspects and embodiments provides methods and formulations for treating inflammatory conditions of the skin and/or conditions involving compromised skin barrier function. Such diseases include blistering diseases of the skin, hereditary defects in skin barrier function, hyperproliferative conditions involving the skin, conditions associated with aging or damaged skin, immunological disorders involving the skin, among others.
1. A method for treating pruritus in an Epidermolysis Bullosa (EB) subject, comprising:
applying to affected areas of the skin of the subject a hypochlorous acid formulation having an amount of hypochlorous acid effective to reduce or inhibit pruritus associated with EB, wherein the hypochlorous acid formulation comprises at least 300 ppm of available free chlorine (AFC), and wherein AFC is at least 80% hypochlorous acid relative to the total of hypochlorous acid, hypochlorite, and Cl 2 in the hypochlorous acid formulation.
2. The method of claim 1 , wherein the hypochlorous acid formulation has AFC of at least 500 ppm.
3. The method of claim 1 , wherein the hypochlorous acid formulation has AFC of at least 700 ppm.
4. The method of claim 1 , wherein the hypochlorous acid formulation has AFC of at least 1000 ppm.
5. The method of claim 1 , wherein the hypochlorous acid formulation has a pH of from 5.4 to 6.4.
6. The method of claim 1 , wherein the hypochlorous acid formulation has a pH of from 5.0 to 6.4.
7. The method of claim 1 , wherein the EB is dystrophic EB.
8. The method of claim 1 , wherein the hypochlorous acid formulation is applied as an alternative or adjunct therapy to topical or oral corticosteroid.
9. The method of claim 1 , wherein the hypochlorous acid formulation is applied to affected areas from 1 to about 10 times daily.
10. The method of claim 1 , wherein the hypochlorous acid formulation is applied periodically to control the pruritus.
11. The method of claim 1 , wherein the hypochlorous acid formulation is applied in a regimen that lasts for from 1 to about 12 weeks.
12. The method of claim 1 , wherein the hypochlorous acid formulation is applied in a regimen that lasts for at least 1 week.
13. The method of claim 1 , wherein the hypochlorous acid formulation is a hydrogel formulation.
14. The method of claim 13 , wherein the hydrogel formulation comprises sodium bicarbonate at from 500 mg/L to 2000 mg/L.
15. The method of claim 13 , wherein the hydrogel formulation comprises a pharmaceutically-acceptable silicate carrier for topical application.
16. The method of claim 1 , wherein the hypochlorous acid formulation is applied to affected areas from 1 to 5 times daily.
17. The method of claim 1 , wherein the hypochlorous acid formulation is applied to affected areas from 1 to 3 times daily.
18. The method of claim 1 , wherein the hypochlorous acid formulation is applied in a regimen that lasts for from 1 to about 8 weeks.
19. The method of claim 1 , wherein the hypochlorous acid formulation is applied in a regimen that lasts for from 1 to about 4 weeks.
20. The method of claim 1 , wherein the hypochlorous acid formulation is applied in a regimen that lasts for at least 2 weeks.
21. The method of claim 1 , wherein the hypochlorous acid formulation is applied in a regimen that lasts for at least 6 weeks.
22. The method of claim 1 , wherein the hypochlorous acid formulation is applied in a regimen that lasts for at least 8 weeks.
23. The method of claim 1 , wherein the hypochlorous acid formulation is applied in a regimen that lasts for at least 10 weeks.
24. The method of claim 1 , wherein the hypochlorous acid formulation is applied in a regimen that lasts for at least 12 weeks.